The emerging therapy of tirzepatide peptide represents a significant development in the handling of type 2 diabetes. Unlike existing therapies, tirzepatide targets multiple pathways – the GLP-1 hormone and GIP – https://tirzepatidepeptide410831.bcbloggers.com/40820602/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment